Virkningen af venlafaxin depot til behandling af større depressive episoder blev fastlagt i 2 placebo- kontrollerede, kortvarige forsøg af 8 og 12 ugers varighed, med doser fra 75 til 225 mg/ dag.
The efficacy of venlafaxine prolonged-release as a treatment for major depressive episodes was established in two placebo-controlled, short-term studies for 8 and 12 weeks duration, which included a dose range of 75 to 225 mg/ day.